Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Too many vessels? Not enough? The wrong kind? The VEGF debate continues.

Nature Medicine volume 7, pages 403–404 (2001)Cite this article

Although angiogenic factors provide hope for patients with ischemic diseases, a whirlwind of controversy surrounds their purported involvement in development of atherosclerosis (pages 425–429).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Schematic diagram of the atherosclerotic plaque.

Bob Crimi

References

  1. Ware, J.A. & Simons, M. Angiogenesis in ischemic heart disease. Nature Med. 3, 158–164 (1997).

    Article  CAS  Google Scholar 

  2. Celletti, F. J. et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nature Med. 7, 425–429 (2001).

    Article  CAS  Google Scholar 

  3. Laham, R.J. et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized double blind placebo controlled trial. Circulation 100,1865–1871 (1999).

    Article  CAS  Google Scholar 

  4. Henry, T. et al. The VIVA trial: One year follow up (abstract). Circulation 102, II–309 (2000).

    Google Scholar 

  5. Post, M.J. & Ware J.A. Angiogenesis in atherosclerosis and restenosis. in Angiogenesis and Cardiovascular Disease (eds. Ware, J.A. & Simons, M.) 143–158. (Oxford University Press, New York, 1999)

    Google Scholar 

  6. Moulton, K. et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99, 1726–1732 (1999).

    Article  CAS  Google Scholar 

  7. Barger, A.C. et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries; a possible role in the pathophysiology of atherosclerosis. N. Engl. J. Med. 310, 175–177 (1984).

    Article  CAS  Google Scholar 

  8. Asahara, T. et al. Bone marrow derived endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation 85, 221–228 (1999).

    Article  CAS  Google Scholar 

  9. Simons, M. et al. Clinical trials in coronary angiogenesis: issues, problems, consensus. Circulation 102, e73–e78 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Molecular Pharmacology and Cardiology Albert Einstein College of Medicine Montefiore Medical Center Bronx, New York, USA

    J. Anthony Ware

Authors
  1. J. Anthony Ware
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ware, J. Too many vessels? Not enough? The wrong kind? The VEGF debate continues.. Nat Med 7, 403–404 (2001). https://doi.org/10.1038/86452

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/86452

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing